HAVN Life Sciences Company Description

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.

mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds.

The company was incorporated in 2020 and is based in Port Moody, Canada.

HAVN Life Sciences Inc.

Country	Canada
Founded	2020
Industry	Biotechnology
Sector	Healthcare
CEO	Tim Moore

Contact Details

Address: 605 - 130 Brew Street Port Moody, British Columbia V3H 0E3 Canada
Phone	604 370 9520
Website	havnlife.com

Stock Details

Ticker Symbol	HAVLF
Exchange	OTCMKTS
Fiscal Year	May - April
Reporting Currency	CAD
ISIN Number	CA4196213058
SIC Code	2836

Key Executives

Name	Position
Tim Moore	Interim Chief Financial Officer, Chief Executive Officer and Chairman
Jenna Pozar	Chief Operations Officer
Paul More	Controller